Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Total Non-Current Liabilities (2016 - 2020)

Historic Total Non-Current Liabilities for Niagen Bioscience (NAGE) over the last 10 years, with Q2 2020 value amounting to $20.2 million.

  • Niagen Bioscience's Total Non-Current Liabilities fell 3072.77% to $20.2 million in Q2 2020 from the same period last year, while for Jun 2020 it was $20.2 million, marking a year-over-year decrease of 3072.77%. This contributed to the annual value of $19.6 million for FY2019, which is 3284.39% up from last year.
  • Latest data reveals that Niagen Bioscience reported Total Non-Current Liabilities of $20.2 million as of Q2 2020, which was down 3072.77% from $18.8 million recorded in Q1 2020.
  • Niagen Bioscience's 5-year Total Non-Current Liabilities high stood at $29.1 million for Q2 2019, and its period low was $6.6 million during Q4 2016.
  • Its 5-year average for Total Non-Current Liabilities is $14.0 million, with a median of $13.2 million in 2016.
  • As far as peak fluctuations go, Niagen Bioscience's Total Non-Current Liabilities surged by 15345.29% in 2019, and later tumbled by 3072.77% in 2020.
  • Over the past 5 years, Niagen Bioscience's Total Non-Current Liabilities (Quarter) stood at $9.4 million in 2016, then decreased by 8.66% to $8.6 million in 2017, then skyrocketed by 72.33% to $14.8 million in 2018, then soared by 32.84% to $19.6 million in 2019, then rose by 2.69% to $20.2 million in 2020.
  • Its last three reported values are $20.2 million in Q2 2020, $18.8 million for Q1 2020, and $19.6 million during Q4 2019.